120 related articles for article (PubMed ID: 8535223)
21. Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1.
Pedersen IM; Kitada S; Leoni LM; Zapata JM; Karras JG; Tsukada N; Kipps TJ; Choi YS; Bennett F; Reed JC
Blood; 2002 Sep; 100(5):1795-801. PubMed ID: 12176902
[TBL] [Abstract][Full Text] [Related]
22. Bcl-2 family gene modulation during spontaneous apoptosis of B-chronic lymphocytic leukemia cells.
Sanz L; Garcia-Marco JA; Casanova B; de La Fuente MT; García-Gila M; Garcia-Pardo A; Silva A
Biochem Biophys Res Commun; 2004 Mar; 315(3):562-7. PubMed ID: 14975737
[TBL] [Abstract][Full Text] [Related]
23. Bcl-2 and bax expression and chlorambucil-induced apoptosis in the T-cells and leukaemic B-cells of untreated B-cell chronic lymphocytic leukaemia patients.
Thomas A; Pepper C; Hoy T; Bentley P
Leuk Res; 2000 Oct; 24(10):813-21. PubMed ID: 10996199
[TBL] [Abstract][Full Text] [Related]
24. Engagement of CD31 delivers an activating signal that contributes to the survival of chronic lymphocytic leukaemia cells.
Poggi A; Prevosto C; Catellani S; Rocco I; Garuti A; Zocchi MR
Br J Haematol; 2010 Nov; 151(3):252-64. PubMed ID: 20813004
[TBL] [Abstract][Full Text] [Related]
25. fas-mediated lysis of chronic lymphocytic leukaemia cells: role of type I versus type II cytokines and autologous fasL-expressing T cells.
Williams JF; Petrus MJ; Wright JA; Husebekk A; Fellowes V; Read EJ; Gress RE; Fowler DH
Br J Haematol; 1999 Oct; 107(1):99-105. PubMed ID: 10520029
[TBL] [Abstract][Full Text] [Related]
26. Significance of phosphotyrosine proteins, Bcl-2 and p53 for apoptosis in resting B-chronic lymphocytic leukemia (CLL) cells.
Laytragoon-Lewin N; Rossmann ED; Castro J; Mellstedt H
Int J Cancer; 2002 Jan; 97(3):344-8. PubMed ID: 11774286
[TBL] [Abstract][Full Text] [Related]
27. Bryostatin induces protein kinase C modulation, Mcl-1 up-regulation and phosphorylation of Bcl-2 resulting in cellular differentiation and resistance to drug-induced apoptosis in B-cell chronic lymphocytic leukemia cells.
Thomas A; Pepper C; Hoy T; Bentley P
Leuk Lymphoma; 2004 May; 45(5):997-1008. PubMed ID: 15291360
[TBL] [Abstract][Full Text] [Related]
28. Non-malignant leukocytes delay spontaneous B-CLL cell apoptosis.
Gamberale R; Geffner J; Arrosagaray G; Scolnik M; Salamone G; Trevani A; Vermeulen M; Giordano M
Leukemia; 2001 Dec; 15(12):1860-7. PubMed ID: 11753606
[TBL] [Abstract][Full Text] [Related]
29. The levels of TNF alpha, IL4 and IL10 production by T-cells in B-cell chronic lymphocytic leukaemia (B-CLL).
Mainou-Fowler T; Miller S; Proctor SJ; Dickinson AM
Leuk Res; 2001 Feb; 25(2):157-63. PubMed ID: 11166831
[TBL] [Abstract][Full Text] [Related]
30. [Apoptosis in chronic lymphocytic leukemia].
Giordano M
Medicina (B Aires); 2000; 60 Suppl 2():12-6. PubMed ID: 11188924
[TBL] [Abstract][Full Text] [Related]
31. Doxorubicin and a butyric acid derivative effectively reduce levels of BCL-2 protein in the cells of chronic lymphocytic leukemia patient.
Rabizadeh E; Bairey O; Aviram A; Ben-Dror I; Shaklai M; Zimra Y
Eur J Haematol; 2001 Apr; 66(4):263-71. PubMed ID: 11380606
[TBL] [Abstract][Full Text] [Related]
32. Thioredoxin prolongs survival of B-type chronic lymphocytic leukemia cells.
Nilsson J; Söderberg O; Nilsson K; Rosén A
Blood; 2000 Feb; 95(4):1420-6. PubMed ID: 10666220
[TBL] [Abstract][Full Text] [Related]
33. Apoptosis in B-chronic lymphocytic leukaemia.
Osorio LM; Aguilar-Santelises M
Med Oncol; 1998 Dec; 15(4):234-40. PubMed ID: 9951686
[TBL] [Abstract][Full Text] [Related]
34. Farnesyltransferase inhibitor BMS-214662 induces apoptosis in B-cell chronic lymphocytic leukemia cells.
Marzo I; Pérez-Galán P; Giraldo P; López-Royuela N; Gómez-Benito M; Larrad L; Lasierra P; Rubio-Félix D; Anel A; Naval J
Leukemia; 2004 Oct; 18(10):1599-604. PubMed ID: 15356656
[TBL] [Abstract][Full Text] [Related]
35. Modulation of IL-4 level by fludarabine and its relation to apoptosis in chronic B-cell lymphocytic leukemia.
Shamaa LA; Hussein Ael-S; Balbaa OA; Farahat NM; Ali MA
Egypt J Immunol; 2008; 15(1):181-92. PubMed ID: 20306682
[TBL] [Abstract][Full Text] [Related]
36. Loss of cooperativity of secreted CD40L and increased dose-response to IL4 on CLL cell viability correlates with enhanced activation of NF-kB and STAT6.
Bhattacharya N; Reichenzeller M; Caudron-Herger M; Haebe S; Brady N; Diener S; Nothing M; Döhner H; Stilgenbauer S; Rippe K; Mertens D
Int J Cancer; 2015 Jan; 136(1):65-73. PubMed ID: 24828787
[TBL] [Abstract][Full Text] [Related]
37. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance.
Thomas A; El Rouby S; Reed JC; Krajewski S; Silber R; Potmesil M; Newcomb EW
Oncogene; 1996 Mar; 12(5):1055-62. PubMed ID: 8649796
[TBL] [Abstract][Full Text] [Related]
38. Assessment of expression of selected Bcl-2 family proteins in lymphoid infiltration in patients with B-cell chronic lymphocytic leukaemia treated with nucleoside analogues.
Lemancewicz D; Dziecioł J; Piszcz J; Lebelt A; Mazgajska-Barczyk K; Klim B; Kłoczko J
Folia Histochem Cytobiol; 2008; 46(3):361-6. PubMed ID: 19056541
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-4 prevents spontaneous in-vitro apoptosis in chronic lymphatic leukaemia but sensitizes B-CLL cells to melphalan cytotoxicity.
Pu QQ; Bezwoda WR
Br J Haematol; 1997 Aug; 98(2):413-7. PubMed ID: 9266941
[TBL] [Abstract][Full Text] [Related]
40. IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells.
Coscia M; Pantaleoni F; Riganti C; Vitale C; Rigoni M; Peola S; Castella B; Foglietta M; Griggio V; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M
Leukemia; 2011 May; 25(5):828-37. PubMed ID: 21372840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]